Stay at home. Follow the rules of quarantine.            Download Arogya Setu Mobile App.            If you think you have symptoms of COVID-19, call nearest hospital immediately.            Adhere to the ‘Lakshman Rekha’ of Lockdown and Social Distancing.            Wear mask at all times while going out of the house.           A homemade mask is as great as the one from market. Don't panic.            Do not hoard essential food, medicine and other such products.            Do not spread rumours.            Follow the instructions issued by AYUSH ministry to enhance your immunity.            Regularly consume warm water, ‘kadha’.            Take care of less fortunate people around you. They too are suffering.            Be compassionate towards the people who work with you in your business or industry. Do not deprive them of their livelihood.            Pay utmost respect to our nation’s Corona Warriors – our doctors and nurses, sanitation workers and police force.            Take special care of the elderly in your homes, especially those who have chronic disease.            Keep yourself active with yoga and exercise at home.            Pray at home. Don't go outside.            Help your tenants, daily wage workers and people with less means around you.           

Vaccine Development

Third phase human trial of COVID-19 vaccine to commence in Bhubaneswar soon

The search for a suitable vaccine for COVID-19 has almost come to the final stage, Dr E Venkata Rao, Principal Investigator in the COVAXIN human trial and Professor in the department of Community Medicine at the Institute of Medical Sciences and SUM Hospital here said on Sunday.

Resources to be in place for viable, effective COVID-19 vaccination system: Niti Aayog

Responding to a question about money required on procuring and distribution of vaccines, he said, "I think it is very premature at the moment to talk about costs, funds and resources required for getting the vaccination... That will depend entirely on what the modalities are, how we go about it."

Bharat Biotech in talks to take COVID-19 vaccine candidate global

The potential vaccine was found to be safe without any major adverse events in the first two stages of the trials involving about 1,000 people, Executive Director Sai Prasad said in a phone interview, adding that more than 90% of them developed antibodies against the novel coronavirus.

COVID-19 vaccine: Covaxin has got approval for phase-III trials, says DG ICMR

During press conference held on October 27, ICMR DG Balram Bhargava said, “Three vaccine candidates in different stages of clinical testing- Covaxin has got approval for phase III trials, Cadila also progressing with phase-II trials and Serum is completing phase 2b trial and has an ongoing trial in Brazil, South Africa and US.”COVID-19 vaccine: Covaxin has got approval for phase-III trials, says DG ICMR

Covid-19 vaccines not near, trials just started

The first batch of 100 participants in the Indian trial of the vaccine developed by University of Oxford and AstraZeneca were inoculated on October 8. Serum Institute of India (SII) is conducting the trials. Results of trials of Oxford and Bharat Biotech won’t be out till 2021.

Centre has decided to distribute COVID-19 vaccine free of cost: Himanta Biswa Sarma

The health minister also said that there is improvement in the COVID-19 scenario in Assam in the last one month. "However, if we can maintain vigil during the ongoing Durga puja festival we will be able to defeat COVID.”

The global hunt for Covid-19 vaccine for kids begins; next up, testing shots in children

When the first shots arrive, they're unlikely to be recommended for children.

Budget will not be a constraint on the rollout of Covid-19 vaccine: Expenditure Secretary TV Somanathan

Expenditure secy says health ministry will take a call on who gets it on priority and the costs

Britain moves closer to COVID-19 vaccine trials that infect volunteers

Preliminary work for the trials, which aim to speed up the process of determining the efficacy of a vaccine candidate, is being carried out by hVIVO, a unit of pharmaceutical services group Open Orphan, the company said.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study

The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients. Participants aged 60 and over were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59, the researchers said.

COVID-19 vaccine will under distributed under special immunization programme: Officials

The existing digital platform and processes used for the Universal Immunisation Programme are being enhanced to track COVID-19 vaccine administration and movement, from procurement to storage to distribution to individual beneficiaries, as and when the vaccine becomes available, the health ministry officials said.

Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's plants shut

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

Covid-19: Government identifying 30 crore who will get vaccine on priority

The list has four categories — around 50-70 lakh healthcare professionals, over two crore frontline workers, including police, municipal workers and armed forces, about 26 crore persons above 50 years of age and another set aged less than 50 but with co-morbidities.

Oxford Covid-19 vaccine doing ‘everything expected', independent study finds

The experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.

Oxford COVID-19 vaccine produces immune response among elderly and young, AstraZeneca says

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.

CEPI labs to help improve Covid-19 vaccine evaluation

The initiative, led by the not for profit Coalition of Epidemic Preparedness and Innovation (CEPI), is looking to bring in as many global vaccine makers working on Covid-19 candidates as possible into it. Data show there are currently more than 300 vaccines under development for Covid-19.

Russia expected to register second COVID-19 vaccine on Oct 15: Developer

The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.

Prepared to administer 1 mn COVID-19 vaccines a day: Apollo Hospitals Group

The group will leverage its pan India web of 19 medicine supply hubs with cold chain facilities and use it's 70 hospitals, over 400 clinics, 500 corporate health centers, 4,000 pharmacies alongside omni-channel digital platform Apollo 24|7 to ensure massive administration capacity of COVID-19 vaccines, Apollo Hospitals Group said in a statement.

Bharat Bio seeks nod for phase-3 trials of indigenous Covid vaccine Covaxin

The company has already approached the states for initiating phase III trials this month. As reported by ET earlier, the company has written to various states including Delhi, Uttar Pradesh, Bihar, Maharashtra, Punjab and Assam, seeking their permission and facilitation to initiate the trial.

As pandemic continues across the globe, where are we in the coronavirus vaccine race?

The U.S. Food and Drug Administration has said it will not approve a vaccine unless it is both effective and safe. On Tuesday, it added more stringent safety guidelines for U.S. vaccines.

China joins deal to get Covid-19 vaccine to poorer nations

China has signed up to a deal to ensure future Covid-19 vaccines are distributed to developing countries, the biggest economy yet to join the World Health Organization-led bid to control the pandemic.

COVID-19 vaccine will be provided free of cost to poor people in Madhya Pradesh: Shivraj Singh Chouhan

Madhya Pradesh Chief Minister Shivraj Singh Chouhan on Thursday said that the COVID-19 vaccine will be made available in the state free of cost to poor people who cannot afford it. Speaking to ANI, Chouhan said, "In Madhya Pradesh, coronavirus cases have been controlled to a large extent and the active cases are getting low. The government is making efforts to have control over this disease. But its permanent cure is the vaccine."COVID-19 vaccine will be provided free of cost to poor people in Madhya Pradesh: Shivraj Singh Chouhan

China's experimental COVID-19 vaccine appears safe: Study

In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its researchers said on Tuesday in a paper posted on medRxiv preprint server ahead of peer review.

Israel to start human trials of COVID-19 vaccine on November 1

The committee is mandated to ensure the well being and rights of trial volunteers and to ensure that the experiment is conducted as per the approved medical guidelines and ethics, besides various domestic laws, rules and regulations.

USFDA approves remdesivir, first drug to treat COVID-19 patients

According to the press release by the company, previously authorised by the FDA for only emergency use to treat COVID-19 patients, Veklury or Remdesivir is now the first and only approved COVID-19 treatment in the United States.

TN CM Palaniswami promises Covid-19 vaccine free of charge as State crosses 7 lakh cases

Addressing media in Pudukkottai district of the state, Palaniswami said, "Once the COVID19 vaccine is ready, it will be provided to all people of the state free of cost."

India to help Myanmar develop COVID-19 vaccine to combat the pandemic

The country announced this during foreign office consultations with Myanmar held virtually on Thursday. The development comes a few weeks after India sealed a deal with Bangladesh to develop anti-Covid vaccine through collaboration between top institutes.

Serum Institute seeks alterations in clinical norms for Covid vaccine

Pune based Serum Institute of India (SII) that is conducting Phase 3 trial of the Oxford Covid-19 vaccine has approached India’s drug regulator seeking approval for changes to its protocol to broaden the horizon of the trials.

Pfizer not yet ready to release COVID-19 vaccine data from late-stage trial

Pharma major Pfizer Inc said the company could release data on whether or not the vaccine works as early as this month.

COVID-19 vaccine may be ready by year-end - WHO's Tedros

Nine experimental vaccines are in the pipeline of the WHO-led COVAX global vaccine facility that aims to distribute 2 billion doses by the end of 2021.

China joins COVAX alliance for global distribution of its COVID-19 vaccines

“This is an important step China has taken to uphold the concept of a shared community of health for all and to honour its commitment to turn COVID-19 vaccines into a global public good,” Foreign Ministry spokesperson Hua Chunying said, apparently refuting reports that China plans to distribute the vaccines to developing countries on its own ahead of developed countries.

Britain to infect healthy volunteers to speed up COVID-19 vaccine efforts

Britain signed a contract with Open Orphan and its London-based unit, hVivo, that paves the way for human challenge trials, the company said on Tuesday. The plan is to manufacture the virus and conduct a study to determine how much of the pathogen to expose volunteers to in the trials.

Covid-19 shots may come under universal immunisation programme

At least 15 states have started feeding data of their healthcare workers in public as well as private sector on a new beneficiary module recently created by the Centre, whereas details for procurement and distribution of Covid-19 vaccine are being worked out by the NECVAC, a health ministry official said.

Electronic Vaccine Intelligence Network to track COVID-19 vaccine

A national expert group on COVID-19 vaccine has been constituted to guide the government on prioritisation of population groups for vaccination, selection of vaccine candidates, delivery mechanism of the vaccine, cold chain and associated infrastructure for roll-out of COVID-19 vaccination, etc. Minister of State for Health Ashwini Kumar Choubey said.

All citizens in the country to get free COVID-19 vaccine: Union Minister Pratap Sarangi

The BJP announcement of free COVID vaccine for Bihar, where assembly polls begin this week, had kicked up a controversy with the opposition parties tearing into the NDA government alleging that the ruling party was using the pandemic for political reasons.

India sets aside $7 bn to vaccinate the world's second biggest population against coronavirus

Prime Minister Narendra Modi’s administration estimates an all-in cost of about $6-$7 per person in the nation of 1.3 billion, the people said, asking not to be identified as the details are private. The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose, they added.

Centre to map out cold chain storage facilities in preparation for COVID-19 vaccine delivery

A national expert group is talking to public and private sector entities in the pharmaceutical sector, food processing industry and agro businesses as well as food delivery start-ups such as Swiggy and Zomato to identify cold storages or fridges at the taluka level that can stock and distribute the vaccine.

Covid-19 & influenza may have similar symptoms, but flu vaccine cannot protect you from coronavirus

The CDC says the vaccine will not cause you to fall ill with the flu.

Chinese company offers coronavirus vaccine to students

China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinical trials.

Drug regulator asks Serum Institute to submit more information on Oxford Covid-19 vaccine

The Pune-based company is conducting phase-3 trials of the Oxford Covid-19 vaccine in India as part of international trials.

Free vaccine in Bihar, are others from Bangladesh? Uddhav Thackeray to BJP

In a veiled attack on actress Kangana Ranaut, Thackeray said some people come to Mumbai for bread and butter and abuse the city by calling it Pakistan occupied Kashmir (PoK).

US likely to have enough COVID-19 vaccines for all vulnerable Americans by year end, says official

The U.S. government is "cautiously optimistic" that one or two vaccines, likely from Pfizer Inc or Moderna Inc , will be available by the end of the year and can begin to be distributed to Americans, officials said during a news conference.

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazilian without revealing where the person lived.

Joe Biden pledges free Covid vaccine for 'everyone' in US if elected

Biden, who has made it a point to follow scientists' guidelines such as wearing facemasks and engaging in social distancing, said that if he is elected he would be focused on bringing the pandemic to heel, and to help struggling Americans with the costs.

PM cautions against complacency in COVID-19 fight; directs full preparedness for vaccine distribution

Chairing a meeting to review the COVID-19 pandemic situation and the preparedness of vaccine delivery, distribution, and administration, the prime minister also noted a steady decline in the daily cases and the growth rate.

YouTube bans coronavirus vaccine misinformation

The video platform said it would now ban any content with claims about COVID-19 vaccines that contradict consensus from local health authorities or the World Health Organization.

Accelerating the end of the COVID-19 pandemic: Bill Gates on Vaccine

Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, delivers a video message at the high-level side event "Accelerating the end of the COVID-19 pandemic".This event hosted by The World Health Organization (WHO), the United Kingdom, South Africa, and the UN Secretary-General aims to build stronger political consensus for a coordinated global response to COVID-19 and champion the importance and urgency of equitable access to new tools, especially effective vaccines. It also seeks to catalyze a step-change in support for the Access to COVID-19 Tools Accelerator (ACT-A), the most promising solution for global equitable access to the tools needed to accelerate the end of the pandemic.Accelerating the end of the COVID-19 pandemic: Bill Gates on Vaccine

Health ministry launches web portal for updates on Covid-19 vaccine development

The ''vaccine web portal'' and the ''National Clinical Registry for COVID-19'' have been developed by the Indian Council of Medical Research (ICMR) and was launched by Union Health Minister Harsh Vardhan, according to a health ministry statement.

Sixty dollar experimental coronavirus vaccine rolled out in east Chinese city

Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine that authorities have been giving to groups such as medical workers.

"Pandemic is rounding the turn. Vaccines are coming. And I look fine!" Trump in Arizona

President Donald Trump was again downplaying the severity of the coronavirus on Monday during a rally in Arizona. "The pandemic is rounding the turn. Vaccines are coming. And I look fine, don't I?" Trump said, speaking in Tucson. (AP)"Pandemic is rounding the turn. Vaccines are coming. And I look fine!" Trump in Arizona

India declines proposal to test Sputnik-V Covid vaccine in large study

India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections.

Moderna COVID-19 vaccine appears safe, shows signs of working in older adults: Study

The study, published in the New England Journal of Medicine, offers a more complete picture of the vaccine's safety in older adults, a group at increased risk of severe complications from COVID-19.

The road to Covid-19 vaccine: Much progress, some hiccups

This week, vaccine makers in India and abroad expanded their manufacturing contracts, some got ready for approvals, and others gave a realistic timeline for launch.

Johnson & Johnson pauses COVID-19 vaccine trials due to unexplained illness in participant

J&J, which reports quarterly financial results on Tuesday morning, said that such pauses are normal in big trials, which can include tens of thousands of people. It said the "study pause" in giving doses of the vaccine candidate was different from a "regulatory hold" required by health authorities. The current case is a pause.

We promise free Covid-19 vaccine while opposition wants to end prohibition: Ravi Shankar Prasad

Union minister for law and justice Ravi Shankar Prasad has defended BJP’s election manifesto promise of creating 19 lakh jobs in Bihar, saying the promise is substantive and based upon the JDU-BJP alliance’s work in the state.

China ropes in more countries for its COVID-19 vaccine trials

On September 25, a Chinese health official said the WHO had given its backing to China's emergency use of experimental vaccines even though clinical trials have not yet been completed.

Covid-19: India reports 53,370 new cases in 24 hours; tally cross 78-lakh mark

With 53,370 new coronavirus infections, India’s total cases surged to 78,14,682 on October 24. The total active cases are 6,80,680 after a decrease of 14,829 in last 24 hours. Total cured cases are 70,16,046 with 67,549 new discharges in last 24 hours. The total number of people died from the virus in India stands at 1,17,956, including 650 new deaths in last 24 hours. According to Indian Council of Medical Research (ICMR), total 10,13,82,564 samples have been tested for COVID-19 up to 23rd October. Of these, 12,69,479 samples were tested yesterday. Covid-19: India reports 53,370 new cases in 24 hours; tally cross 78-lakh mark

Very large portion of COVID-19 vaccines likely to be manufactured in India: Gates Foundation CEO

In an interview to, Suzman noted that India is doing everything it can right now with the resources at hand to fight the COVID-19 pandemic.

China's COVID-19 vaccines

China, the original epicenter of the coronavirus, has publicly displayed its COVID-19 vaccines - for the first time - at a trade fair in Beijing.

COVID-19 vaccine ready & coming within weeks: Trump at final presidential debate with Biden

The coronavirus dominated the opening minutes of the Trump-Biden face-off in Nashville with President Trump terming the contagion a “worldwide problem”.

Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan

The study will recruit 160 people aged 20 to 85, the companies said in a statement.

UNICEF to lead the supply of COVID-19 vaccines globally

In what could possibly be the world's largest and fastest ever operation of its kind, UNICEF has announced that it will be leading the procurement and supply of coronavirus vaccines to ensure that all countries have safe, fast and equitable access to initial doses when they are available.

Russian scientist behind COVID-19 vaccine defends 'wartime' roll-out

Russia has pushed ahead with its potential COVID-19 vaccine at top speed with mass public vaccinations alongside the main human trial, raising concerns among some observers that it was prioritising national prestige over solid science and safety.

Covid-19: With 55,838 new cases, India’s tally crosses 77-lakh mark

With 55,838 new COVID-19 cases, the virus has now infected 77,06,946 people in India on October 22. As many as 702 deaths were reported in the last 24 hours, taking the tally to 1,16,616. Total active cases stands 7,15,812, after a decrease of 24,278 in last 24 hours. Total cured cases are 68,74,518 with 79,415 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), total 9,86,70,363 samples tested for COVID-19 up to 21th October. Of these, 14,69,984 samples were tested yesterday. Covid-19: With 55,838 new cases, India’s tally crosses 77-lakh mark

What is likely to affect EC's reading of BJP's vaccine promise

While the opposition has demanded sou moto action by Election Commission on the BJP promising free Covid-19 vaccines in its Bihar poll manifesto, the poll panel is said to be closely looking at a 2019 precedence and provisions of the Representation of People’s Act, 1950 on the issue which do not warrant so.

Early Covid-19 treatments could be ‘bridge’ to vaccine: Anthony Fauci

“We are focusing very heavily now on the treatment of early infection and, or prevention of infection,” Fauci told the Journal of the American Medical Association in an interview Friday. “And that's the bridge to the vaccine.”

AstraZeneca pauses COVID-19 vaccine trial in UK due to unexplained illness of participant

UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom. The vaccine, which AstraZeneca is developing with the University of Oxford, has been described by the World Health Organization (WHO) as probably the world's leading candidate and the most advanced in terms of development.AstraZeneca pauses COVID-19 vaccine trial in UK due to unexplained illness of participant

China gives unproven COVID-19 vaccines to thousands, with risks unknown

The world still lacks a proven COVID-19 vaccine, but that has not stopped Chinese officials from trying to inoculate tens of thousands, if not hundreds of thousands, of people outside the traditional testing process.

50% efficacy level for approval of Covid-19 vaccines not enough: Experts

The criterion was declared even before an Indian Council of Medical Research taskforce on Covid-19 could take up the matter. “Has this been vetted by public health experts? The criteria have not even been discussed in the ICMR taskforce,” said a member of the ICMR task force, requesting anonymity.

Refer to poll schedule to know when one will be inoculated: Rahul on BJP's 'free vaccine' promise

Congress leader Rahul Gandhi on Thursday took a swipe at the BJP for promising free COVID-19 vaccine in its Bihar poll manifesto, saying one has to refer to the state-wise election schedule to know when one will have access to vaccine.

World Bank says India can use funds for vaccine plans

The World Bank’s $1-billion support package to help India fight the novel coronavirus can be used for the country’s Covid-19 vaccine programme, an official of the global financial institution said.

Pause and Proceed: More downs than ups in this week's search for Covid-19 vaccine

In the third leg of its vaccine trial, Johnson and Johnson said it was halting the trial after one of the participants developed an unknown illness. The company said such pauses are not uncommon in clinical trials, and the number of serious adverse events (SAE) can reasonably be expected to increase in trials involving a large number of participants. Further, as many trials are placebo-controlled, it is not always immediately apparent whether a participant received a placebo.

UK study tests if BCG tuberculosis vaccine protects against coronavirus

Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been shown to protect against infection or severe illness with other respiratory pathogens.

India expected to have COVID-19 vaccine in next few months: Harsh Vardhan

Union Health Minister Harsh Vardhan made the comments at the Annual General Meeting of Indian Red Cross Society (IRCS) and St. John's Ambulance.

States, Union Territories asked to get storage facilities ready for Covid-19 vaccines

The government expert group on vaccines, which looks into the procurement of Covid-19 vaccines from India and abroad and the guiding principles for prioritisation of groups for vaccination, has proposed setting up a digital platform to track procurement and record administration.

COVID-19 vaccine rollout unlikely before fall 2021, experts say

An effective vaccine is not likely to be available for the general public before the fall of 2021, according to experts working in the field of vaccine development. Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020.

Covid warriors: Volunteers who are helping speed up vaccine launch in India

Trial participants must have normal levels for blood pressure and blood sugar. Pregnant women and children are not allowed to be part of the trial. Participants are monitored for next six months for any possible side effects. They also must refrain from drinking alcohol for two months after receiving the dose. Participants receive Rs 500 as transport charges.

Kool-ex and IndoSpace to jointly develop warehouses for COVID-19 vaccine

As part of the asset-light deal, Kool-ex and IndoSpace will jointly design and set-up 10-11 warehouses by 2023, making it the largest Pharma storage footprint in the country.

Single-dose COVID vaccine tested, experts assure 'no corners cut' at US Congress hearing

A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves. Hopes are high that answers about at least one of several candidates being tested in the U.S. could come by year's end, maybe sooner.Single-dose COVID vaccine tested, experts assure 'no corners cut' at US Congress hearing

IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for Covid-19

A phase-I clinical trial is expected to start in early 2021.

India's Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Serum Institute, the world's largest vaccine maker by the number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally rather than via injection.

University of Houston partners Indian-American co-founded company for COVID-19 vaccine

AuraVax, however, has the option to exclusively license a new intranasal vaccine technology developed by its Indian-American co-founder, Navin Varadarajan, M.D. AuraVax describes its vaccine administration platform as 'next-generation', one which could be administered at home.

Donald Trump insists US 'rounding the turn' on coronavirus

President Donald Trump is asserting that even without a vaccine, "we're rounding the turn," he again told supporters at a New Hampshire rally on Sunday. "It's ending anyway," he said. "But we want normal life to resume." But data from Johns Hopkins University shows new COVID-19 cases at a high, with 83,718 infections reported Saturday, just shy of the 83,757 on Friday.Donald Trump insists US 'rounding the turn' on coronavirus

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its "Solidarity" trial had concluded that remdesivir appeared to have little or no effect on 28-day mortality or length of hospital stays among patients with the respiratory disease.

How Russia shortened the Covid vaccine race in rush to declare victory

The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China. Initial results from final-stage studies won’t be ready until November, with full data expected next year.

Bihar elections 2020: Opposition reacts to BJP’s ‘free Covid vaccine’ clause in manifesto

BJP’s ‘free COVID-19 vaccine to all’ clause in the Bihar elections manifesto draws heavy criticism from Opposition. The Bharatiya Janata Party on Thursday released its manifesto for the Bihar Assembly Elections 2020. The manifesto, titled ‘Paanch sutra, ek lakshya, 11 sankalp’ was released by Union Finance Minister Nirmala Sitharaman in Patna. In its ‘Sankalp Patra’, the BJP has promised free Covid vaccination for all in Bihar once ICMR approves a vaccine.Bihar elections 2020: Opposition reacts to BJP’s ‘free Covid vaccine’ clause in manifesto

Bihar Assembly Elections 2020: BJP releases manifesto; promises free Covid vaccination for all

The Bharatiya Janata Party on Thursday released its manifesto for the Bihar Assembly Elections 2020. The manifesto, titled ‘Paanch sutra, ek lakshya, 11 sankalp’ was released by Union Finance Minister Nirmala Sitharaman in Patna. In its ‘Sankalp Patra’, the BJP has promised free Covid vaccination for all in Bihar once ICMR approves a vaccine.Bihar Assembly Elections 2020: BJP releases manifesto; promises free Covid vaccination for all

Pan-India COVID-19 genome studies suggest virus genetically stable, no major mutation: PMO

There had been concerns in some quarters that any major mutation detected in the novel coronavirus could hinder the development of an effective vaccine. However, some recent global studies have said the vaccines currently being developed for COVID-19 should not be affected by recent mutations.

Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

BJP's use of COVID-19 vaccine as election sop ‘political immorality', says Anand Sharma

The Congress leader also asked the PM whether he wants "vaccine for votes, or vaccine for all".

Most Indians want to get vaccinated for Covid-19 pandemic: Survey

The World Economic Forum-Ipsos survey of nearly 20,000 adults from 27 countries, unveiled on Monday, showed that 87% urban Indians and 74% global citizens are keen to receive the vaccine shot when it is available.

Therapeutic, vaccines for whole world is only way out of this pandemic: Harsh Vardhan

World Health Organization (WHO) Executive Board Chairman and Union Health Minister of India, Dr Harsh Vardhan on October 05 attended 5th special session of WHO executive board via video conferencing. In the event, Vardhan said, “Therapeutic, diagnostics & vaccines for whole world, only way out of this pandemic. Global collaboration is paramount. Strengthening emergency preparedness & risk management, key to addressing health risk posed by emerging diseases.”Therapeutic, vaccines for whole world is only way out of this pandemic: Harsh Vardhan

EU reviewing Pfizer-BioNTech COVID-19 vaccine in real time

Pfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early testing on humans, while continuing talks to submit data as it emerged.

Delhi: Herd immunity only through vaccination

The third sero survey in Delhi, which has revealed that seroprevalence has declined to 25.1%, instead of going up, has made one thing clear: we cannot depend on Covid-19 to run its course in order to develop herd immunity.

Covid-19: Mask not more effective than vaccine, says Donald Trump

Despite Robert Redfield, the director of the US Centers for Disease Control and Prevention, saying that wearing a mask would be more effective than a vaccine against the coronavirus, President Donald Trump said that the mask is "not more effective" than the vaccine "by any means".Covid-19: Mask not more effective than vaccine, says Donald Trump

GSK to widen COVID-19 antibody treatment trial after safety clearance

The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation, typically a life threatening disease stage.

COVID-19 again? Reinfection cases raise concerns over immunity

The report was published just hours after U.S. President Donald Trump, who was infected with COVID-19 and hospitalised earlier this month, said he believes he now has immunity and felt "so powerful".

Ray of Hope

COVID 19 UPDATES  

Created By:
Yaduvanshi Ankit Yaduvanshi Ankit
Managed By (Follow for updates):
Himanshi Yaduvanshi Himanshi Yaduvanshi Sakshi Rana Shivali Nagar

Sponsored By:
Contact to sponsor the campaign.
Recently Added:
  • Support for Multiple language.
  • Precautionary measures.
  • Helplines across India.
  • Update on measures taken by Indian Government in public interest.
  • Table sorting by clicking on column names.
  • Analysis updated every day.

Upcoming:
  • Analysis for India (including Indian States and UT).
  • Analysis for top 20 worst hit countries.

Quick Global Facts

Last Updated: October 28 2020 01:30:06
Total Countries/Areas Affected 212
Total Cases 44142071
Total Deceased 1169664
Total Recovered 31860701
Active Cases 8685264
Total New Cases Today 369317
Total Deceased Today 5418
Deaths/Case (%) 2.65

Key Points (14 September)

  • India is now contributing more than 30% to world's new COVID-19 cases and more than 20% to world's new COVID-19 death cases every day.

  • India crosses Brazil to become the second most COVID-19 affected country in the world on 6th September.

  • India is now consistently recording highest number of new cases in the world. (6th August)

  • World COVID-19 death rate is on a rise again. (20th July)

  • India crosses one million COVID-19 cases on 17th July 2020.

  • Before August starts, India will take over Brazil as the country with second highest numbers of new COVID-19 cases detected per day, consistently.

  • USA, Brazil and India are more than a dozen week away from their peak.

  • India takes over Russia as the third worst COVID-19 hit country on 5th July 2020.

  • COVID-19 testing has doubled for India in last 4 weeks.

  • India completes 10 million tests on 5th July 2020.

  • India has crossed Russia almost a week before the prediction, reflecting the growth in cases that India has seen in last 2 weeks.

  • India currently stands 5th in number of tests done. However, number of tests per million is 4th lowest among top 20 worst hit countries.

  • Mexico is at the same stage that India was at 5 weeks ago.

  • US, Brazil, India and Mexico have seen a spike in number of cases per day this week.

  • Tamil Nadu becomes the first state in India to do a million tests.

  • Peru and Chile will rise to 5th and 6th worst COVID-19 hit countries by 10th July 2020.

  • In Russia and Iran, the number of COVID-19 cases per day has been constant-like for many weeks now. This suggests an unfamiliar pattern from all other countries.

  • Delhi becomes the 2nd worst hit state in India as it takes over Tamil Nadu on 23rd June, 2020.

  • Brazil recorded the most number of cases in a day for any country with 55,209 cases on 19th June 2020.

  • By 14th July 2020, India will take over Russia in term of total number of cases to become the third worst hit country.

  • 20 countries are growing at more than 1000 cases per day.

  • India is the 8th most affected country in terms of total number of deaths due to COVID-19.

  • Peru became the 7th worst hit COVID-19 country on 15th June 2020.

  • The testing numbers are increasing in India as for the first time India tests 150,000 cases in a day on 14th July 2020. India need to quadruple these numbers really soon.

  • India became the fourth worst COVID-19 hit country on 12 June 2020.

  • India's is surprisingly growing at a slightly slower rate than what was predicted (200K cases by 7 June, 2020) by our model.

  • Our model predicts that in 12 weeks from now, India will have the third highest number of COVID-19 cases.

  • Our model predicts a minimum of 1000 COVID-19 cases for every day for next 18 weeks for India.

  • India under Lockdown 5.0 - Unlock 1.0.

  • Death per cases, worldwide, is decreasing significantly for past week.

  • Growth of total cases per day has slowed down, but is still above 1 (above 1 means still growing).

  • Maharashtra becomes the first state in India to reach a 100,000 COVID-19 cases.

  • USA moves from 1 million to 2 million cases in 51 days.

  • Brazil is growing at the same alarming rate at which USA has grown for past 8 weeks. If testing increases, the average per day numbers are set to go higher than USA.